Compare RAYMED LABS. with BACIL PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RAYMED LABS vs BACIL PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    RAYMED LABS BACIL PHARMA RAYMED LABS/
BACIL PHARMA
 
P/E (TTM) x -6.6 -17.1 - View Chart
P/BV x - 4.0 - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 RAYMED LABS   BACIL PHARMA
EQUITY SHARE DATA
    RAYMED LABS
Mar-21
BACIL PHARMA
Mar-21
RAYMED LABS/
BACIL PHARMA
5-Yr Chart
Click to enlarge
High Rs16 15.7%   
Low Rs12 60.5%   
Sales per share (Unadj.) Rs00-  
Earnings per share (Unadj.) Rs-0.2-0.4 39.8%  
Cash flow per share (Unadj.) Rs-0.1-0.4 37.1%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs-4.82.4 -203.6%  
Shares outstanding (eoy) m4.275.89 72.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio xNMNM-  
Avg P/E ratio x-5.9-9.5 62.7%  
P/CF ratio (eoy) x-6.5-9.7 66.7%  
Price / Book Value ratio x-0.21.6 -12.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m423 18.0%   
No. of employees `000NANA-   
Total wages/salary Rs m01 38.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m00-  
Other income Rs m01 9.5%   
Total revenues Rs m01 9.5%   
Gross profit Rs m-1-3 23.0%  
Depreciation Rs m00 120.0%   
Interest Rs m00 0.0%   
Profit before tax Rs m-1-2 28.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m00-   
Profit after tax Rs m-1-2 28.9%  
Gross profit margin %NMNM- 
Effective tax rate %00.2 0.0%   
Net profit margin %NMNM- 
BALANCE SHEET DATA
Current assets Rs m13 29.8%   
Current liabilities Rs m2327 85.5%   
Net working cap to sales %NMNM- 
Current ratio x00.1 34.9%  
Inventory Days DaysNMNM- 
Debtors Days DaysNMNM- 
Net fixed assets Rs m237 4.4%   
Share capital Rs m4365 65.5%   
"Free" reserves Rs m-63-51 123.2%   
Net worth Rs m-2114 -147.6%   
Long term debt Rs m00-   
Total assets Rs m340 6.3%  
Interest coverage xNM-47.0-  
Debt to equity ratio x00-  
Sales to assets ratio x00-   
Return on assets %-27.3-5.9 463.3%  
Return on equity %3.4-17.2 -19.5%  
Return on capital %3.4-16.9 -19.8%  
Exports to sales %NMNM-  
Imports to sales %NMNM-  
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m0-4 0.0%  
From Investments Rs mNA5 0.0%  
From Financial Activity Rs mNA-1 0.0%  
Net Cashflow Rs m01 0.0%  

Share Holding

Indian Promoters % 28.4 42.7 66.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 71.6 57.3 125.0%  
Shareholders   1,478 6,514 22.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare RAYMED LABS With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Indian Indices End Flat Amid High Volatility; Maruti Suzuki & Tech Mahindra Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.

Related Views on News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

4 'Digital India' Stocks to Add to Your 2022 Watchlist(Views On News)

Jan 28, 2022

Digitisation is touching every aspect of our lives. As this megatrend picks up pace, there will be companies benefitting from it for years to come.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

Insiders are Buying into these 6 Stocks Aggressively. More Details here...(Views On News)

Jan 19, 2022

While promoter holding is an important parameter, it should not be the sole reason for buying a stock.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

RAYMED LABS SHARE PRICE


Jan 24, 2022 (Close)

TRACK RAYMED LABS

  • Track your investment in RAYMED LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

RAYMED LABS - VAISHALI PHARMA COMPARISON

COMPARE RAYMED LABS WITH

MARKET STATS